Glaukos Corporation
Glaukos Corporation
Explore linked clinical trials.13 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| iDose TR Administration in an Office-Based Surgery Setting | eye disorder, glaucoma, ocular hypertension, open-angle glaucoma | Recruiting | Not stated | 2026-09-30 | NCT07816692 | |
| Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant | eye disorder, glaucoma, ocular hypertension, open-angle glaucoma | Recruiting | Phase 2 | 2026-09-17 | NCT07075718 | |
| Evaluate the Safety and Feasibility of Same-Day Bilateral Epithelium-On Corneal Cross-Linking for Keratoconus | corneal disorder, eye disorder, keratoconus | Recruiting | Phase 4 | 2026-06-05 | NCT07629557 | |
| Travoprost Intraocular Implant + iStent Infinite | eye disorder, glaucoma, ocular hypertension, open-angle glaucoma | Recruiting | Phase 4 | 2026-06-02 | NCT06066645 | |
| Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant | eye disorder, glaucoma, ocular hypertension, open-angle glaucoma | Recruiting | Phase 3 | 2026-03-30 | NCT07495852 | |
| Evaluation of the Safety and Efficacy of GLK-321 in Subjects With Demodex Blepharitis | Demodex Blepharitis | Recruiting | Phase 2 | 2026-02-27 | NCT07400965 | |
| Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg | eye disorder, glaucoma, ocular hypertension, open-angle glaucoma | Recruiting | Not stated | 2026-02-27 | NCT07400926 | |
| Placebo-controlled Study to Evaluate the Safety and Efficacy of GLK-221 Ophthalmic Solution in Subjects With Keratoconus | corneal disorder, eye disorder, keratoconus | Recruiting | Phase 2 | 2026-02-10 | NCT07400952 | |
| Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone | eye disorder, glaucoma, ocular hypertension, open-angle glaucoma | Recruiting | Phase 4 | 2026-01-21 | NCT06848946 | |
| Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma | exfoliation glaucoma, exfoliation syndrome, eye disorder, glaucoma, iris disorder, ocular hypertension, open-angle glaucoma, uveal disorder | Recruiting | Phase 4 | 2025-11-14 | NCT07228221 | |
| A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED | Persistent Corneal Epithelial Defect | Recruiting | Phase 2 | 2025-07-24 | NCT05966493 | |
| Changes in Eye Pressure in Glaucoma Patients Treated with Istent Inject W, Monitored by a Contact Lens Sensor | cataract, eye disorder, glaucoma, lens disorder, ocular hypertension | Recruiting | Not applicable | 2025-03-06 | NCT06607705 | |
| Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma | eye disorder, glaucoma, ocular hypertension | Recruiting | Not applicable | 2023-09-28 | NCT06057051 |